C irculating nutrients and metabolites provide useful indicators of biological processes in the human body, and their concentrations in biofluids have been used for clinical risk assessment, diagnosis, prognosis and monitoring of therapeutic outcomes [1] [2] [3] [4] . Abnormal concentrations of circulating metabolites and nutrients are associated with health conditions such as metabolic syndrome and cardiovascular disease. Wearable devices [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] , such as wearable sweat sensors 15-23 , have the potential to capture changes in health rapidly, continuously and non-invasively. For example, chloride concentration in sweat is the gold standard to diagnose cystic fibrosis 20 , and glucose concentration in sweat is being intensively explored for diabetes management 16, 20, 24 .
adhesive and inlet-engraved polyethylene terephthalate (PET) and medical adhesive layers ( Fig. 1b and Supplementary Fig. 1 ). As sweat flows into the system, the LEG-CS measures the dynamics of sweat UA and Tyr while the LEG-PS measures skin temperature and strain-related physiological patterns (for example, respiration rate or heart rate) continuously ( Fig. 1c,d ). In addition, sweat loss and sweat rate can be obtained with the circular patterns of microfluidic channels. Two laser-engraving modes are used: raster mode is utilized for chemical sensors while vector mode is used for microfluidic patterns and physical sensors ( Supplementary Figs. 2 and 3 ). Such multimodal microfluidic sensor patches can be prepared at a large scale ( Supplementary Fig. 4 ). The resulting LEG structures are characterized using Raman and X-ray photoelectron spectroscopies ( Supplementary Figs. 5 and 6 ). The disposable patch is connected to a reusable flexible printed circuit board (FPCB) ( Fig. 1d-f) . The system-level block diagram in Fig. 1e and the circuit diagram in Supplementary Fig. 7 illustrate the flow of electrical signals in the electrochemical and physical sensor measurements. For chemical sensing, the preprogrammed microcontroller generates the desired stimulation waveform (smoothened by an analog low-pass filter) to apply a specific sensing voltammogram on the electrodes through an external digital-to-analog converter. The resulting current response is amplified and converted to voltage by a transimpedance amplifier (TIA) and read by an analog-to-digital converter (ADC). Differential pulse voltammetry (DPV) is chosen here to evaluate ultralow-level sweat UA and Tyr on the basis of the amplitude of the oxidation current peak (Fig. 1g ). The responses of the physical sensors are acquired through voltage dividers and the ADC. The acquired data are wirelessly transmitted to the user device over Bluetooth for further analysis.
Characterization of the LEG-based UA and Tyr sensor. Owing to its unique electrochemical properties arising from the fast electron mobility, high current density and ultralarge surface area, graphene is an appropriate candidate for building high-performance sensors to detect ultralow levels of electroactive analytes in body fluids. Laser cutting has been used to directly obtain graphene structures from a variety of substrates toward energy storage and fluid capture applications [45] [46] [47] . Here we manufactured highly sensitive LEG-CS on polyimide via raster mode ( Fig. 2a-d and Supplementary Fig. 2) . The three-electrode LEG-CS could selectively catalyze the oxidation of UA and Tyr at specific potentials (Fig. 2b) . After optimization on the basis of the DPV peak amplitudes of UA and Tyr in the standard solutions ( Supplementary Fig. 8 and Supplementary Table 1 ) and electrochemical impedance spectroscopy ( Supplementary  Fig. 9 Fig. 18 ). The LEG-CS is mechanically flexible, fully compliant with the skin and exhibits mechanical and electrochemical stability ( Supplementary Fig. 19 ).
Design and characterization of the LEG-based vital-sign monitor. The LEG has unique properties for designing resistive physical sensors: as the temperature rises, its conductivity increases owing to increased electron-phonon scattering and thermal velocity of electrons in the sandwiched layers 49 (Fig. 3a) ; when an external strain is applied, its three-dimensional porous structure is compressed, resulting in decreased resistance (Fig. 3b ). Here the LEG-based temperature and piezoresistive strain sensors are fabricated in vector mode (Fig. 3c,d and Supplementary Fig. 2 ). Both material morphology and sensor layout are important in achieving the desired sensor performance: the fiber-like structure resulted from a high dose of local laser power ( Fig. 3d and Supplementary Fig. 20 ) coupled with a straight-line design (strain sensor) yields the highest strain response; the compact structure ( Fig. 3c ) coupled with serpentine line design (temperature sensor) is less susceptible to strain variations (Fig. 3e ).
The temperature sensor shows a fast, accurate and stable response to temperature variations with a sensitivity of −0.06% °C −1 and a low detection limit of 0.051 °C (Fig. 3f-h and Supplementary  Fig. 21 ), which indicates the negative temperature coefficient behavior of the LEG. The strain sensor is fabricated at a low laser speed for large strain response and high stability (Fig. 3i,j and Supplementary  Fig. 22 ), which is ideally suited for accurate monitoring of respiration rate ( Fig. 3k ) and heart rate ( Supplementary Fig. 23 validated with commercial vital monitors ( Supplementary Fig. 24 ). After 10,000 bending cycles, the flat-state resistance of the strain sensor remains stable ( Supplementary Fig. 25 ). The temperature and strain sensor response can be accurately monitored by the FPCB ( Supplementary Fig. 26 ). Considering that the response of the UA and Tyr sensor can be influenced by temperature variations (Fig. 3l ), the temperature sensor readings could be used for realtime chemical sensor calibration during on-body use.
Design and performance characterization of the laser-engraved microfluidics. Laser engraving enables rapid bulk manufacturing of microfluidic devices 50 . The microfluidic module is fabricated in vector mode to fully cut through double-sided adhesives ( Fig.  4a,b ). The use of microfluidics enhanced the sweat sampling process and achieved higher temporal resolution for wearable sensing by constantly supplying newly secreted sweat to the sensor. In response to inflow of solutions at a new solute concentration, the time taken for the solute concentration in the reservoir to adjust to the new concentration (referred to as the refreshing time hereafter) is a key performance indicator of the microfluidic module. We used numerical simulations to determine the effects of the inlet number and flow rates on the refreshing time ( Fig. 4c,d ). For the case of ten inlets, with an experimentally measured sweat rate (1.5 µl min −1 ) as the inlet flow rate, the refreshing time taken to reach 90% of the new solute concentration was around 2.5 min, for a change of solute concentration from 20 µM to 80 µM ( Fig. 4e ). During the on-body trials, the microfluidic patch effectively sampled sweat with high temporal resolution ( Fig. 4f and Supplementary Fig. 27 ). Moreover, it monitored sweat rate or sweat loss on different body parts through optical image analysis 19 ( Supplementary Fig. 28 ; Methods). Wireless and continuous sensing capabilities of the microfluidic-based sensor are performed via continuous analyte solution injection at physiological sweat rates ( Fig. 4g -i). The sensor patch reliably and continuously measured the UA and Tyr levels (±0.49% and ±1.07%, respectively) through successive DPV scans over a 15-cycle period ( Fig. 4h and Supplementary Fig. 29a ). When the input solution was switched from 20 to 80 µM for UA and from 50 to 200 µM for Tyr, the patch took less than 3 min to reach a new stable reading with a hysteresis of ~1 min ( Fig. 4i and Supplementary Fig. 29b ), indicating the high temporal resolution of the microfluidic sensing system. As illustrated in Supplementary Fig. 30 , with a 45-s scan cycle every 2.5 min, the microfluidic system showed very stable readings for UA and Tyr sensing during five successive scans (±1.25% and ±3.24 %, respectively) even when the flow rate was as small as 0.25 µl min −1 , indicating that the molecular depletion in the confined reservoir during DPV scans will not affect the sensing accuracy.
In vivo system validation of the wearable sensor. The fully integrated system could be comfortably worn on different body parts ( Fig. 5a ). Real-time measurement of sweat UA and Tyr, respiration rate and temperature from the neck of a healthy individual in a controlled cycling exercise was demonstrated ( Fig. 5b and Supplementary Fig. 31 ). The temperature increased initially and stabilized after 600 s and the respiration rate (obtained via fast Fourier transform as shown in Supplementary Fig. 32 ) followed similar trends. On the other hand, a decreased trend in sweat UA and Tyr concentrations was observed, which is likely attributable to profuse sweat secretion 40 . Varied UA and Tyr secretion at different locations was observed (Fig. 5c,d and Supplementary Fig. 33 ). We determined the accuracy of the wearable sensor for analyzing raw sweat samples using high-performance liquid chromatography (HPLC) and commercial colorimetric assay kits ( Fig. 5e, Considering that sweat Tyr may be related to fitness condition 41 , we carried out controlled human performance trials on five physically untrained and five trained subjects (athletes) to validate the system (Fig. 5g,h ). As expected, we observed lower sweat Tyr concentrations in trained athlete subjects (Fig. 5h ). The sensor patch was able to dynamically monitor the Tyr intake and supplementation, as well as metabolism ( Supplementary Fig. 37 ). As both tyrosine and uric acid are metabolic products of protein diets, system validations toward nutritional and metabolic monitoring were performed through a protein intake study on three healthy individuals. Higher levels of both sweat UA and Tyr were observed in all the subjects after a high-protein diet ( Supplementary Fig. 38 ). Evaluation of the wearable sensor for non-invasive gout management. The global burden of gout is increasing 34 . Gout is often characterized by chronic hyperuricemia, an elevated UA level exceeding the physiological saturation threshold 31 . Many risk factors, such as an increased intake of dietary purines and alcohol 33 , can lead to gout attacks (Fig. 6a ). Monitoring serum UA is important in personalized gout treatment and management (for example, urate-lowering therapy, flare-up preventions and dietary or nutritional control) 31 . To evaluate our sensor for gout management, we performed a controlled purine-diet study in healthy male and female subjects. For subjects with overnight fasting (n = 6), both serum and sweat UA levels increased after a purine-rich diet (Fig.  6b-e and Supplementary Figs. 39) . The subsequent human study, carried out 2 h after a regular lunch, indicated that higher sweat UA levels were identified from the subjects with hyperuricemia (n = 4) and patients with gout (without medication, n = 6) than from the healthy subjects (n = 5), with a similar trend in serum UA levels ( Fig. 6f and validated in Supplementary Fig. 40 with HPLC ). This approach also shows promise for personalized dosage adjustment in urate-lowering therapy, as illustrated in Supplementary Fig. 41 . The dynamic changes of sweat UA before and after a purine-rich diet over a 7-h period measured by the wearable sensor ( Fig. 6g ) closely resembled those of serum UA. We obtained a high correlation coefficient of 0.864 between sweat and serum UA concentrations ( Fig. 6h ), suggesting the potential use of sweat UA as a biomarker for gout management.
Discussion
Given the rich physiological information present in human sweat, the transition from traditional blood analysis to in situ sweat analysis using wearable sensors could provide a non-invasive, continuous means to monitor metabolites and to guide personalized nutritional and metabolic management. However, current wearable sweat sensors face several major challenges: (1) the lack of available highly sensitive wearable sensors that can monitor sweat analytes beyond a few electrolytes and metabolites via ion-selective or enzymatic sensors; (2) the low in situ sensing accuracy owing to factors such as skin contamination, sweat evaporation and long refreshing time; and (3) the lack of correlation study between the sweat analyte level and a particular health condition. Our laser-engraved multimodal sensor enables efficient microfluidic sweat sampling, sensitive molecular sensing and multiplexed vital-sign sensing. Owing to its fast electron mobility, high current density and ultralarge surface area, the graphene-based chemical sensor achieves rapid and accurate detection of UA and Tyr in human sweat in situ. Moreover, its manufacture is likely scalable as all three key modules (physical sensors, chemical sensors, and microfluidic module) are fabricated with a widely available CO 2 laser engraving approach. We have demonstrated sweat UA and Tyr detection using a wearable system and correlated our results with serum measurements in both healthy subjects and patients with gout. The high correlation coefficient obtained in our small pilot study indicates the promise of this approach for personalized monitoring of UA levels. Further studies may also assess its value in noninvasive monitoring of gout, cardiovascular disease, type 2 diabetes and renal disease.
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Methods
Materials and reagents. UA, l-tyrosine, silver nitrate, iron chloride (III), dopamine hydrochloride, choline chloride, creatinine, pantothenic acid calcium salt, citrulline, pyridoxine and lactic acid were purchased from Alfa Aesar. Sodium thiosulfate pentahydrate, sodium bisulfite, tryptophan, leucine, alanine, isoleucine, methionine, valine, lysine, thiamine hydrochloride and serine were purchased from Sigma Aldrich. Potassium ferricyanide (III) was purchased from Acros Organics. Acetic acid, sodium acetate, sodium chloride, urea, l-ascorbic acid and dextrose (d-glucose) anhydrous, glycine, arginine, inositol, ornithine, aspartic acid, threonine, histidine, riboflavin, creatine, phenylalanine, nicotinic acid, folic acid and glutamic acid were purchased from Thermo Fisher Scientific. Medical adhesives were purchased from Adhesives Research. Polyimide film (75 μm thick) and PET (12 μm and 75 μm thick) were purchased from DuPont and McMASTER-CARR, respectively. Glassy carbon electrodes were purchased from CH Instruments, screen-printed carbon electrodes were purchased from Metrohm AG and gold electrodes were fabricated on a PET substrate by photolithography followed by 30 nm Cr/100 nm gold deposition via electron-beam evaporation and lift-off in acetone.
Fabrication and characterization of the LEG. For sensor patterning, a polyimide film (DuPont) was attached onto a supporting substrate in a 50-W CO 2 laser cutter (Universal Laser System). The optimized parameters for the chemical sensor were power 6.3%, speed 5.5%, points per inch (PPI) 1,000 and raster mode. After graphene electrodes were scribed, silver was electrodeposited onto one pattern to function as the reference electrode at −0.2 mA for 100 s using a plating solution containing 250 mM silver nitrate, 750 mM sodium thiosulfate and 500 mM sodium bisulfite. The physical sensors had their contact pads scribed with the same parameters as the chemical sensors. For the active sensing area of the strain sensor, the optimized parameters were power 0.3%, speed 1.0% (1.4%, 1.2% and 1.0% were described as higher speed, medium speed and lower speed, respectively, in Fig. 3i and Supplementary Fig. 22 ), PPI 400, vector mode; for the active sensing area of the temperature sensor, the optimized parameters were power 1.5%, speed 11%, PPI 1,000 and vector mode. Scanning electron microscopy (SEM) images were taken with a field emission scanning electron microscope (FEI Sirion). The surface properties of the laser-induced graphene were characterized by X-ray photoelectron spectroscopy (Escalab 250xi, Thermo Fisher Scientific). The Raman spectrum of graphene was recorded using a 532.8-nm laser with an inVia Reflex (Renishaw). Characterization of the strain and temperature sensors. The temperature sensor characterization was performed on a ceramic hot plate (Thermo Fisher Scientific) ( Fig. 3f,g and Supplementary Fig. 21 ). The sensor response was recorded using a parameter analyzer (Keithley 4200A-SCS) and compared with the readings from an infrared thermometer (LASERGRIP 800; Etekcity). The response of the strain sensor was recorded using the parameter analyzer (Keithley 4200A-SCS) in a controlled temperature atmosphere (23 ± 1 °C). The accuracy of the strain sensor for heart rate and respiration rate monitoring was validated on a healthy subject with a commercially available vital-sign monitor (Masimo MightySat; Supplementary Fig. 24 ). Under repetitive bending under a 0.1% strain for 10,000 cycles (performed using a Lynxmotion AL5D 4DOF Robotic Arm), the mechanical deformation effect on LEG-based electrode was evaluated ( Supplementary Fig. 25 ).
Characterization of the

Fabrication and characterization of microfluidic channels.
A double-sided medical adhesive was attached to a substrate in the above-mentioned laser cutter. One layer of medical adhesive was cut through to make the channels and the reservoir, and another layer of medical adhesive was used to interface skin with inlets. The cylindrical reservoir has a radius of 2.13 mm, a thickness of 140 µm (medical tape) and its volume can thus be calculated as ~2 µl. The microfluidic channels have a depth of 140 µm and a width of 175 µm. Between two layers lies a thin (12 µm) and transparent PET film. The optimized laser cutter parameters were power 1%, speed 1.5%, PPI 1,000 for reservoir outline and channels, and power 2%, speed 1%, PPI 1,000 for inlet outlines, all in vector mode. The sweat rates were measured via optical image analysis on the basis of the photographs of a microfluidic patch taken sequentially on the different body parts of the subjects. The estimated sweat rates were calculated by the sweat volume changes divided by the time intervals. For Fig. 4f , black dye was dropped in the reservoir, and a transparent 75-µm PET film was used instead of the polyimide layer to prepare the microfluidics for better visibility. An assembled flow patch was attached onto a subject's arm after an iontophoresis session implemented using a Model 3700
Macroduct Sweat Collection System. The flow tests were done with a syringe pump (Thermo Fisher Scientific, 78-01001) and set concentrations of UA and Tyr in ABS. The DPV data were wirelessly transmitted to a laptop computer and automatically converted to concentration via custom-developed software.
Refreshing time analysis and simulations.
A ballpark estimate of the concentration refreshing time T c can be obtained by considering the mass balance of a standard well-mixed model: dC/dt + (C − C i )Q/V r = 0, where C i and Q denote, respectively, the new solute concentration and total flow rate into the reservoir, and V r represents the reservoir volume. This simple ordinary differential equation can be solved analytically to obtain the solute concentration in the reservoir as a function of time t, C t
, where C 0 is the initial concentration in the reservoir. Hence, the refreshing time taken for the reservoir to reach a concentration of kC i can be readily calculated as
. For an experimentally measured sweat rate of Q = 1.5 µl min −1 and concentration change from C 0 = 20 µM to C i = 80 µM, we estimate that the designed reservoir volume V r = 2 mm 3 leads to a refreshing time T c ≈ 2.7 min to reach k = 90% of the new concentration. This simple analysis provides an order of magnitude estimate of the required refreshing time by assuming perfect mixing. To obtain more realistic estimates, a three-dimensional model was created with the same geometry of the device. The mass transport process was simulated using a finite-element software COMSOL Multiphysics by numerically solving the Stokes equation for an incompressible flow
Here p and v denote, respectively, pressure and flow velocity, whereas µ and D denote, respectively, solvent viscosity and solute diffusivity. The Stokes equation is applicable here because the Reynolds number is on the order of 10 −2 for this microfluidic device. The solute concentration in the chamber is tracked by computing the average concentration over the bottom surface of the chamber. A flow rate of 0.15 µl min −1 is prescribed at each inlet, with the no-slip boundary condition on all channel walls. The simulated refreshing time as a function of the number of inlets is displayed in Fig. 4c . The refreshing time decreases as the number of inlets increases; for ten inlets with a total inlet flow rate of 1.5 µl min −1 , the simulated 90% refreshing time is ~2.5 min, slightly less than the ballpark estimate on the basis of perfect mixing (~2.7 min). In Fig. 4d , the time evolution of the average concentration under different total inlet flow rates is displayed. In Fig. 4e , the concentration distribution over the bottom surface of the chamber is displayed at different time instances. Similarly, numerical simulation was performed on the basis of the actual design of the microfluidic module used in this work ( Supplementary Fig. 27 ).
Signal conditioning, processing and wireless transmission.
At the core of the system lied an STM32L432 ultralow-power ARM Cortex-M4 32-bit microcontroller with a built-in 12-bit ADC (Fig. 1e ). The microcontroller was programmed with the ST-link/v2 in-circuit debugger and programmer. For a DPV scan, the microcontroller controlled the DAC8552 digital-to-analog converter through the serial peripheral interface (SPI) protocol to output a steady reference potential for the reference electrode, and a dynamic working potential for the working electrode. A fourth-order low-pass filter further stabilized the reference potential. The analog circuitry for the filter, potentiostat interface and TIA are shown in Supplementary Fig. 7 . The resulting current through the working electrode was amplified and converted to voltage by the TIA, then read by the ADC peripheral of the microcontroller. The 12-bit ADC had a high sample rate of five million samples per second, allowing precise and time-accurate measurements by taking averages. The default incremental potential of the DPV scan is 0.004 V unless otherwise noted, which leads to a scan cycle of 90 s. The potential steps could be increased to obtain short scan cycles ( Supplementary Figs. 17 and 30 ). The microcontroller was also able to measure the resistance of the vital-sign sensors through voltage divider circuits and the built-in ADC. The acquired multimodal data were wirelessly transmitted via Bluetooth to the user device and further analyzed via custom-developed software. As the output of the electronic system is electrical potential, the wirelessly collected raw signals were plotted in mV in the figures.
Power delivery. The entire system operated at 3.3 V, enabling a simple and efficient design. A single LD39050 voltage regulator converted the power from a 3.7 V Liion battery to a stable 3.3 V. During data acquisition and transmission, the FPCB drew 27 mA from the 3.7 V Li-ion battery. Using a 400-mAh battery, the device could perform approximately 592 full cycles of the 90-s DPV measurements.
Human subject recruitment. The validation and evaluation of the sweat sensor were performed using human subjects in compliance with all the ethical regulations under a protocol (ID 19-0892) that was approved by the Institutional Review Board (IRB) at California Institute of Technology. The participating subjects (age range 18-65) were recruited from the California Institute of Technology campus and the neighboring communities through advertisement. All subjects gave written informed consent before participation in the study.
On-body system validation.
To validate the multimodal sweat sensor, we conducted constant-load cycling exercise on five physically trained and five physically untrained subjects (all male). The trained subjects (athletes from California Institute of Technology sport teams) exercised regularly for at least 9 h per week while the untrained subjects had an average of 1 h of exercise per week. The subjects reported to the lab with overnight fasting and were given a standardized protein drink (Fairlife, Core Power Elite). Two hours after the protein consumption, the subjects' foreheads and necks were cleaned with alcohol swabs and gauze before the sensor patches were placed on the body. A stationary exercise bike (Kettler Axos Cycle M-LA) was used for cycling trials. The subjects cycled at 60 rpm for 40 min. During the on-body trial, the data from the sensor patches were wirelessly sent to the user interface via Bluetooth. When the subjects started biking, the sensor system continuously acquired and transmitted physical sensor data at a rate of 10 Hz. Every minute, the electronic system initiated a transient voltage bias between the reference and working electrodes. If the bias triggered a current above an experimentally determined threshold, the system would start the first 90-s DPV scan. The DPV scan was repeated every 5 min until the subject stopped biking. After being calibrated using simultaneously collected skin temperature information in the preprogrammed microcontroller (Fig. 3l) , the acquired molecular data were wirelessly transmitted via Bluetooth to the user device, and further converted to the concentration levels on the basis of the calibration curves in Fig. 5e ,f. The respiration rate was calculated through spectral analysis by performing fast Fourier transform on the respiration sensor data ( Supplementary Fig. 32 ). The frequency corresponding to the largest amplitude in the frequency spectrum was converted to breaths per minute. Meanwhile sweat samples were collected periodically from the forehead and neck of the subjects using centrifuge tubes and then centrifuged at 6,000 rpm for 15 min. The sweat samples were then frozen at −20 °C for further testing and validation via electrochemical test with the LEG-CS, HPLC analysis and the colorimetric assay kits. For the tyrosine supplementation study, the subject consumed 1.5 g tyrosine 6 min after an iontophoresis session implemented using a Model 3700 Macroduct Sweat Collection System. Over a 50-min period, the subject's sweat was sampled periodically and analyzed by the sensor patch while the sweat flow rate was estimated by the sweat volume in each sampling period ( Supplementary Fig. 37 ).
HPLC analysis for sensor validation and sample analysis. HPLC tests of UA
and Tyr were done on HP Agilent 1100 HPLC using an Agilent Eclipse XDB-C18 5 µm 3 × 250 mm column. Tests of UA and Tyr were done with gradient methods and the gradient profiles are shown in Supplementary Tables 3 and 4 . Detection wavelengths for UA and Tyr were 245 nm and 274 nm, respectively. Retention times were ~9 min and ~4 min for UA and Tyr, respectively. Sweat samples and serum samples were diluted to around 400 µl, both with water. The selectivity study of the HPLC was performed by spiking a constant concentration of UA or Tyr with different sweat analytes with concentrations listed in Supplementary Table 2 .
Colorimetric assays for sensor validation and sample analysis. For UA analyses, the QuantiChrom Uric Acid Assay kit (BioAssay Systems) was used for the determination of UA levels in sweat. The kit quantifies UA in the sample by utilizing 2,4,6-tripyridyl-s-triazine, which forms a blue-colored complex with iron in the presence of UA. Five microliters of samples and standard solutions were transferred in triplicate wells of a clear-bottom 96-well plate, followed by addition of 200 µl of working reagents. The microplate was incubated for 30 min at room temperature. The absorbance at a wavelength of 620 nm was measured using a microplate photometer (Multiskan FC) and the concentration of uric acid was calculated according to the standard curve (n = 3). Standard kits and solutions were kept at 4 °C and −20 °C unless otherwise used. For Tyr analyses, the Tyrosine Assay kit (Cell Biolabs) was used for the determination of Tyr levels in sweat. The kit quantifies the colorimetric intermediate formed via enzymatic oxidation of Tyr. Fifty microliters of samples and standard solutions were transferred in triplicate wells of a clear-bottom 96-well plate, followed by addition of 50 µl of working reagents. The microplate was incubated for 10 min at room temperature on an orbital shaker. The absorbance at a wavelength of 450 nm was measured using a microplate photometer (Multiskan FC) and the concentration of tyrosine was calculated according to the standard curve (n = 3).
Human trials for gout management. To evaluate the sensor performance toward gout management, a purine-rich diet study was performed on both healthy male and female subjects (Fig. 6b-e and Supplementary Fig. 39 ). The subjects reported to the lab after overnight fasting. Fresh capillary blood samples were collected using a finger-prick approach before the exercise. After cleaning the fingertip with alcohol wipe and allowing it to air dry, the skin was punctured with CareTouch lancing device. Samples were collected with centrifuge tubes after wiping off the first drop of blood with gauze. After the 90-min standardized clotting procedure finished, serum was separated by centrifuging at 6,000 rpm for 15 min, and instantly stored at −20 °C for HPLC analysis. A 20-min constant-load cycling exercise was immediately conducted on the subjects after the blood collection with the sweat information collected by the sensor patch from the forehead. The subjects were then given a purine-rich diet (250 g of canned sardines) followed by a 2-h rest. The blood collection and the cycling trial were then repeated. The plotted data for this study are based on the first two successive complete DPV measurements. To further characterize the sweat UA sensing, six patients with gout, four subjects with hyperuricemia (without history of gout attack) and five healthy subjects were recruited (Fig. 6f ). It should be noted that all of the six patients with gout (three currently under urate-lowering therapy, three not on any medical therapy) didn't receive any urate-lowering medication for at least 10 h ahead of the study. The sweat samples and blood samples were collected 2 h after their regular lunch and tested by the sensor patches and HPLC, respectively (same procedure as the after meal test in the meal challenge study). During the on-body test, sweat samples were collected periodically from the subjects using centrifuge tubes and then frozen at −20 °C for further sensor validation via HPLC analysis. For dynamic monitoring of UA before and after purine intake (Fig. 6g ), a healthy subject underwent a finger-prick blood collection followed by a 20-min cycling test after overnight fasting, then consumed canned sardines. The blood collection and sweat test were repeated periodically every hour until 6 h after the intake. The collected blood samples were analyzed with HPLC. To investigate the medication influence on serum and sweat UA levels, a patient with gout underwent the sweat and blood sample tests on two days: on one day the patient received urate-lowering medication (allopurinol) 2 h before the test and on the other day the patient did not take medication for 24 h before the test. The sweat samples and blood samples were collected 2 h after their regular lunch and tested by the sensor patches and HPLC, respectively (same procedure as the after meal test in the meal challenge study). The correlation plot in Fig. 6h was based on data obtained from 15 subjects (including six patients with gout). The Pearson correlation coefficient was acquired through linear regression in Origin 2018 (n = 46).
